Targeting Lipid Metabolism for Better Management of Coronavirus SARS-COV-2 Infections: Intervention, Antiviral Drug Development, and Challenges
Journal of Cellular Signaling · 2024
DOI: 10.33696/signaling.5.116 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular Signaling, 2024. Verfasst von Yuting Wang und 2 weiteren Autor:innen.
Abstract (Originalsprache)
The global pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), although has faded from public view, the virus itself remains highly active and continues to mutate, continuously causing infections.
Zitieren
APA
Wang, Y., Chen, P., & He, M. (2024). Targeting Lipid Metabolism for Better Management of Coronavirus SARS-COV-2 Infections: Intervention, Antiviral Drug Development, and Challenges. Journal of Cellular Signaling. https://doi.org/10.33696/signaling.5.116
Vancouver
Wang Y, Chen P, He M. Targeting Lipid Metabolism for Better Management of Coronavirus SARS-COV-2 Infections: Intervention, Antiviral Drug Development, and Challenges. Journal of Cellular Signaling. 2024. doi:10.33696/signaling.5.116
BibTeX
@article{Wang2024,
author = {Wang, Yuting and Chen, Peiran and He, Ming-Liang},
title = {Targeting Lipid Metabolism for Better Management of Coronavirus SARS-COV-2 Infections: Intervention, Antiviral Drug Development, and Challenges},
journal = {Journal of Cellular Signaling},
year = {2024},
doi = {10.33696/signaling.5.116}
}
EUVIMED